Molecular mechanisms of apoptosis in HL-60 cells induced by a nitric oxide-releasing compound. 1997

M Yabuki, and S Kariya, and Y Inai, and K Hamazaki, and T Yoshioka, and T Yasuda, and A A Horton, and K Utsumi
Department of Cell Chemistry, Okayama University Medical School, Japan.

Nitric oxide (NO) generated from 1-hydroxy-2-oxo-3, 3-bis(2-aminoethyl)-1-triazene (NOC 18), an NO-releasing compound, induced monocytic differentiation of human promyelocytic leukemia HL-60 cells as assessed by expression of nonspecific esterases and morphologic maturation. Simultaneously, DNA fragmentation and morphological alterations typical of apoptosis were also induced. To investigate the mechanisms of apoptosis during differentiation of HL-60 cells induced by NO, the endogenous levels of Bcl-2 and Bax were assessed by immunoblotting. Treatment of cells with NOC 18 slightly reduced the level of Bcl-2 followed by Bax. These changes might be involved in the induction of apoptosis. The involvement of the activation of the interleukin-1 beta converting enzyme (ICE) family of proteases (caspases), such as ICE and CPP32, in the pathways was also investigated. CPP32, but not ICE, was strongly activated in response to NOC 18 stimulation, thereby implicating CPP32-like activity in the induction of apoptosis. Moreover, the possible involvement of tyrosine phosphorylation in apoptosis was investigated. Pretreatment of cells with herbimycin A, an inhibitor of tyrosine kinases, suppressed DNA fragmentation and CPP32-like activity, whereas pretreatment with vanadate, an inhibitor of tyrosine phosphatases, enhanced both parameters, suggesting that tyrosine phosphorylation might be involved in the pathways of apoptosis in HL-60 cells induced by NO.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D009603 Nitroso Compounds Organic compounds containing the nitroso (-N Compounds, Nitroso
D011809 Quinones Hydrocarbon rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Yabuki, and S Kariya, and Y Inai, and K Hamazaki, and T Yoshioka, and T Yasuda, and A A Horton, and K Utsumi
January 1999, Advances in experimental medicine and biology,
M Yabuki, and S Kariya, and Y Inai, and K Hamazaki, and T Yoshioka, and T Yasuda, and A A Horton, and K Utsumi
January 1998, Cellular immunology,
M Yabuki, and S Kariya, and Y Inai, and K Hamazaki, and T Yoshioka, and T Yasuda, and A A Horton, and K Utsumi
April 2020, Chemico-biological interactions,
M Yabuki, and S Kariya, and Y Inai, and K Hamazaki, and T Yoshioka, and T Yasuda, and A A Horton, and K Utsumi
October 1999, Archives of biochemistry and biophysics,
M Yabuki, and S Kariya, and Y Inai, and K Hamazaki, and T Yoshioka, and T Yasuda, and A A Horton, and K Utsumi
March 1997, Biochemical and biophysical research communications,
M Yabuki, and S Kariya, and Y Inai, and K Hamazaki, and T Yoshioka, and T Yasuda, and A A Horton, and K Utsumi
April 2008, Zhongguo shi yan xue ye xue za zhi,
M Yabuki, and S Kariya, and Y Inai, and K Hamazaki, and T Yoshioka, and T Yasuda, and A A Horton, and K Utsumi
August 2005, Zhongguo shi yan xue ye xue za zhi,
M Yabuki, and S Kariya, and Y Inai, and K Hamazaki, and T Yoshioka, and T Yasuda, and A A Horton, and K Utsumi
December 1997, Cancer letters,
M Yabuki, and S Kariya, and Y Inai, and K Hamazaki, and T Yoshioka, and T Yasuda, and A A Horton, and K Utsumi
June 2000, Free radical research,
M Yabuki, and S Kariya, and Y Inai, and K Hamazaki, and T Yoshioka, and T Yasuda, and A A Horton, and K Utsumi
July 1995, The Journal of biological chemistry,
Copied contents to your clipboard!